CRISPR Therapeutics AG (NAS:CRSP) Stock News, Headlines & Updates
CRISPR Therapeutics AG Stock News from GuruFocus
- 1
- 2
Jun 30, 2025
CRISPR Therapeutics AG (CRSP) Recognized in TIME's 100 Most Influential Companies List | CRSP stock news
GuruFocus News • 7:03am
CRISPR Therapeutics Named to TIME's Most Influential Companies List of 2025
Marketwired • 7:00am
Jun 27, 2025
CRSP: Analyst Downgrade and Price Target Announced | CRSP Stock News
GuruFocus News • 1:30pm
CRSP: Piper Sandler Reiterates Overweight Rating with $105 PT | CRSP Stock News
GuruFocus News • 12:00pm
CRISPR Therapeutics (CRSP) Maintains Market Outperform Rating | CRSP Stock News
GuruFocus News • 8:00am
CRISPR Therapeutics (CRSP): Analyst Reiterates Buy Rating | CRSP Stock News
GuruFocus News • 7:31am
CRSP Downgraded to Hold Amid Valuation Concerns | CRSP Stock News
GuruFocus News • 4:31am
Jun 26, 2025
CRSP Stock Rating Reiterated with Buy Recommendation by Analyst | CRSP Stock News
GuruFocus News • 11:01am
CRSP Stock News: Analyst Maintains Buy Rating with $82 Price Target | CRSP Stock News
GuruFocus News • 10:30am
Crispr Therapeutics (CRSP) Reports Promising Phase I Results for CTX310 | CRSP Stock News
GuruFocus News • 9:47am
CRISPR Therapeutics (CRSP) Delays Key Phase 1 Trial Data for CTX320
GuruFocus News • 7:56am
CRSP Updates on In Vivo Cardiovascular Programs | CRSP Stock News
GuruFocus News • 6:31am
CRISPR Therapeutics Reports Positive Additional Phase 1 Data for CTX310â„¢ Targeting ANGPTL3 and Provides Update on In Vivo Cardiovascular Pipeline | CRSP Stock News
GuruFocus News • 6:20am
CRISPR Therapeutics AG (CRSP) Announces Promising Updates in Cardiovascular Gene Therapy Programs | CRSP stock news
GuruFocus News • 6:01am
CRISPR Therapeutics Reports Positive Additional Phase 1 Data for CTX310â„¢ Targeting ANGPTL3 and Provides Update on In Vivo Cardiovascular Pipeline
Marketwired • 6:00am
Jun 10, 2025
Crispr Therapeutics (CRSP) Rallies Amid FDA Fast-Tracking News
GuruFocus News • 3:59pm
Jun 05, 2025
CRSP Sees Significant Increase in Bullish Option Activity | CRSP Stock News
GuruFocus News • 12:45pm
May 30, 2025
ARK Investment Expands Stake in Crispr Therapeutics (CRSP) | CRSP Stock News
GuruFocus News • 8:30pm
May 29, 2025
CRISPR Therapeutics AG (CRSP) Announces Participation in Upcoming Investor Conferences | CRSP stock news
GuruFocus News • 8:07am
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
Marketwired • 8:00am
CRISPR Therapeutics to Participate in Upcoming Investor Conferences | CRSP Stock News
GuruFocus News • 7:49am
May 28, 2025
ARK Investment Increases Stake in Crispr Therapeutics (CRSP) | CRSP Stock News
GuruFocus News • 8:15pm
May 21, 2025
CRSP Stock Outlook: JMP Securities Reiterates Market Outperform Rating | CRSP Stock News
GuruFocus News • 8:30am
May 20, 2025
Bullish Options Activity Signals Interest in Crispr Therapeutics (CRSP) | CRSP Stock News
GuruFocus News • 11:45am
CRSP: Needham Reiterates Buy Rating with $81 Price Target | CRSP Stock News
GuruFocus News • 11:01am
CRISPR (CRSP) Partners with Sirius for siRNA Therapy Development
GuruFocus News • 9:55am
CRSP: HC Wainwright & Co. Maintains Buy Rating for CRISPR Therapeutics | CRSP Stock News
GuruFocus News • 6:31am
May 19, 2025
CRISPR Therapeutics AG (CRSP) Announces Strategic Partnership with Sirius Therapeutics | CRSP stock news
GuruFocus News • 4:04pm
Crispr Therapeutics (CRSP) Enters Alliance with Sirius Therapeutics for siRNA Innovation | CRSP Stock News
GuruFocus News • 4:00pm
CRISPR Therapeutics and Sirius Therapeutics Announce Multi-Target Collaboration to Develop Novel siRNA Therapies
Marketwired • 4:00pm
CRISPR Therapeutics and Sirius Therapeutics Announce Multi-Target Collaboration to Develop Novel siRNA Therapies | CRSP Stock News
GuruFocus News • 3:32pm
May 16, 2025
CRISPR (CRSP) Gene Editing Breakthrough Shows Promise in Custom Pediatric Treatment
GuruFocus News • 6:55am
May 09, 2025
CRISPR Therapeutics (CRSP) Downgraded Amid Market Challenges
GuruFocus News • 12:56pm
CRISPR Therapeutics (CRSP) Price Target Lowered by Barclays | CRSP Stock News
GuruFocus News • 8:32am
Crispr Therapeutics (CRSP) Price Target Reduced by Barclays to $42 | CRSP Stock News
GuruFocus News • 5:18am
May 08, 2025
CRISPR Therapeutics (CRSP): Goldman Sachs Lowers Price Target to $47 | CRSP Stock News
GuruFocus News • 10:33am
May 07, 2025
CRSP Sees Price Target Adjustment by BofA Amid Key Updates | CRSP Stock News
GuruFocus News • 9:45am
CRSP: Needham Maintains Buy Rating Despite Target Price Reduction | CRSP Stock News
GuruFocus News • 8:02am
CRSP Stock: Analyst Maintains Buy Rating, Lowers Price Target | CRSP Stock News
GuruFocus News • 6:31am
Crispr Therapeutics (CRSP) Upgraded to Buy by Clear Street Analyst | CRSP Stock News
GuruFocus News • 5:35am
- 1
- 2
Show
Entries
Headlines
Total 0- 1
No recent news